We investigated the efficacy of combination therapy with SRC and MEK inhibitors in several MPNST cell models and found out that combined MEK/SRC inhibitor treatment exerted synthetic lethality by inducing cell apoptosis in MPNST. The gene discussed is SRC; the disease is malignant peripheral nerve sheath tumor.